BVS - Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 40 ^th Annual J.P. Morgan Healthcare Conference via webcast on Wednesday, January 12, 2022, at 5:15 p.m. ET.

The live webcast of the presentation, including Q&A, will be available on the Investors section of the Bioventus website and will be archived on that site.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and surgical solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com , and follow the Company on LinkedIn and Twitter . Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Media Contact:
Thomas Hill
919-474-6715
thomas.hill@bioventus.com

Investor Inquiries:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com